CNS nongerminomatous germ cell tumor (NGGCT)

Also called Central nervous system nongerminomatous germ cell tumor

CNS nongerminomatous germ-cell tumors are a varied group of brain tumors that includes several germ-cell histologies and mixed tumors. Imaging, tissue when appropriate and tumor markers distinguish them from pure germinoma and other brain tumors.

Other names and abbreviations

CNS NGGCT, NGGCT, intracranial non-germinomatous germ cell tumor, CNS non-germinoma, brain germ cell tumor, Intracranial nongerminomatous germ cell tumour

In short

  • CNS nongerminomatous germ cell tumors are a varied group of brain tumors, told apart from pure germinoma by scans, tumor marker tests and sometimes a tissue sample.
  • Treatment usually combines several chemotherapy drugs with radiation, plus surgery for tumor that remains in some cases, based on markers, spread, tumor type and response.
  • For some tumors that come back, or in specialist plans, high-dose chemotherapy may be followed by a return of the patient's own stem cells, with no donor needed.
Jump to a section

Underlined words open a short explanation. See all terms

Where transplant fits

followed by can be considered in selected recurrent disease or specialist protocols. This uses the patient’s own cells; it does not require a registry donor, and benefit varies with disease context.

Treatment depends on the exact diagnosis, disease stage, prior treatment and the person’s health.

Key facts

Who it affects
These tumors mainly affect children, adolescents and young adults.
Usual treatment
Treatment usually combines multi-drug chemotherapy and radiotherapy, with surgery for selected residual disease. The plan depends on tumor markers, spread, response and the specific histology.
Cells used in a transplant
The patient’s own collected blood-forming cells for autologous stem cell rescue, when that procedure is appropriate.
Where a donor fits
Limited transplant role

Support for patients and families

These independent organizations offer information and support. JBF is not affiliated with them.

Questions to bring to your care team

  • What is the exact name of the diagnosis or subtype, and what does it mean for treatment?
  • What is the goal of each treatment you are suggesting?
  • What would make a transplant worth considering later on?
  • Are there clinical trials that might fit?
  • Where can our family find support during treatment?

Supporting someone with a diagnosis

Sources and further reading

  1. Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ)
    NCI, Accessed 2026-09-05
  2. Indications for haematopoietic cell transplantation and CAR-T: 2025 EBMT practice recommendations
    EBMT / Bone Marrow Transplantation, Accessed 2026-09-05
  3. Stem Cell and Bone Marrow Transplants for Cancer
    NCI, Accessed 2026-09-05

Other patients are waiting for a match.

Most people with CNS nongerminomatous germ cell tumor (NGGCT) are treated without a registry donor. Many people with other blood cancers and blood disorders need a donor who is a stranger.

Join the registry

JBF points you to the official registry that serves your country. It explains who can join and what donation involves.

Help a family run a drive

If someone you love needs a donor, a registration drive can add many potential donors at once, for them and for others.

Support this work

Gifts to the Jada Bascom Foundation support donor-awareness education like this guide, community outreach, drive planning and referrals to official registries.

Donate to JBF

We respect your privacy. Unsubscribe anytime.

Keep learning